BLACR - BELLEVUE LIFE SCIENCES ACQUISITION CORP
This page shows which of the focused investors we track hold BLACR and how their positions changed, so you can see how much conviction the group has in the stock.
In Q1 2023 it was held by 1 manager with an aggregate reported value of $28.88K, which is 0.00% of the combined portfolio.
As of Q1 2023, 1 tracked institutional manager held BLACR (BELLEVUE LIFE SCIENCES ACQUISITION CORP) with an aggregate reported value of $28.88K — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades BLACR — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q1 2023
- Ticker
- BLACR
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Howard Marks - Oaktree Capital Management | 0.00% | New | 175,000 | $28.88K |
Loading holder history for BLACR…